Price to Book Value Chart

View Price to Book Value for ORXOF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
September 18, 2026 1.804
September 17, 2026 1.804
September 16, 2026 1.804
September 15, 2026 1.804
September 14, 2026 1.804
September 11, 2026 1.804
September 10, 2026 1.804
September 09, 2026 1.804
September 08, 2026 1.804
September 04, 2026 1.804
September 03, 2026 1.804
September 02, 2026 1.804
September 01, 2026 1.804
August 31, 2026 1.804
August 28, 2026 1.804
August 27, 2026 1.804
August 26, 2026 1.804
August 25, 2026 1.804
August 24, 2026 1.804
August 21, 2026 1.804
August 20, 2026 1.942
August 19, 2026 1.942
August 18, 2026 1.942
August 17, 2026 1.942
August 14, 2026 1.942
Date Value
August 13, 2026 1.942
August 12, 2026 1.942
August 11, 2026 1.942
August 10, 2026 1.942
August 07, 2026 1.942
August 06, 2026 1.942
August 05, 2026 1.942
August 04, 2026 1.942
August 03, 2026 1.942
July 31, 2026 1.942
July 30, 2026 1.942
July 29, 2026 1.942
July 28, 2026 1.942
July 27, 2026 2.218
July 24, 2026 2.218
July 23, 2026 2.218
July 22, 2026 2.218
July 21, 2026 2.218
July 20, 2026 2.218
July 17, 2026 2.218
July 16, 2026 2.218
July 15, 2026 2.631
July 14, 2026 2.631
July 13, 2026 2.631
July 10, 2026 2.631

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Swedencare AB 0.5013
Camurus AB 7.599
Moberg Pharma AB 0.7646
Infant Bacterial Therapeutics AB 16.84
AstraZeneca PLC 10.88

Price to Book Value Related Metrics

PS Ratio 3.658
PEG Ratio -0.0251
Price to Free Cash Flow 37.59
Price 1.44
Earnings Yield -65.84%
Market Cap 50.58M
PEGY Ratio -0.0251